The debenture holders committee has kick started the process to sell several key subsidiaries of Anil Ambani led Reliance Capital over the weekend. CNBC-TV18 learned that the committee has expressions of interest (EoI) for sale in Reliance Capital companies by December 1st.

Dabur will report its Q2 numbers on November 3 and the Street is expecting health, hygiene and immunity products to lead domestic revenue growth. However, out of home products like juices and some skincare products may not do well due to the lockdown. Likewise, international business is expected to see subdued growth of 3 to 5 percent.

Subhash Chandra’s debt-laden Essel Grouphas been in talks with NIIF to sell these assets since last year for an estimated Rs 1,500-1,800 crore.

Speaking to CNBC-TV18, B Ramesh Babu, MD & CEO of Karur Vysya Bank, said, "Earlier our aspirational number was around 1.75 percent to maintain the slippage ratio. I think we will be able to manage with that until and unless something crops up suddenly."